Rick Caimi has nearly 20 years experience in the biopharmaceutical industry spanning virtual biotech organizations through large Pharma. In his current role as Director of Early Phase CMC Development, Rick is responsible for leading development activities supporting Pre-Clinical and Phase I/II manufacturing for all BioPharms in GSKs growing development pipeline. He received his Ph.D. in biochemistry from Cornell University in 1995.
Important Notice: Limited Web Access Dec 16 to 18, 2016
AIChE will undertake a routine upgrade of our digital infrastructure over the weekend of December 16-18, 2016. During this period access to certain areas of the website will be limited. Learn more about how access will be affected.